U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807749) titled 'Adjuvant Treatment in Premenopausal Breast Cancer' on Jan. 10.
Brief Summary: Multicentric retroprospective observational study to collect outcome in premenopausal breast cancer patients who undergone the 21-multigene assay Oncotype DX from 1st January 2013 to 31st December 2022 and adjuvant treatment.
Study Start Date: Feb., 2025
Study Type: OBSERVATIONAL
Condition:
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Published by HT Digital Content Services with permission from Health Daily Digest....